Evidence map›Paper›PMID 20133624›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2010

Activation state and intracellular trafficking contribute to the repertoire of endogenous glycosphingolipids presented by CD1d [corrected].

Karen Muindi, Manuela Cernadas, Gerald F M Watts, Louise Royle, David C A Neville, Raymond A Dwek, Gurdyal S Besra, Pauline M Rudd, Terry D Butters, Michael B Brenner

Erratum issuedOpen access · greenAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 36 papers.

0numbers the graph read from it
0cells of the map it votes in
36citing papers in PubMed
2.9field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

36 citing papers in PubMed, 54 citations in OpenAlex.

  1. Review
  2. Review
  3. Insights into the CD1 lipidome.Frontiers in immunology · 2024
    Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Review
  12. Article
  13. Article
  14. Review
  15. Review
  16. The CD1 size problem: lipid antigens, ligands, and scaffolds.Cellular and molecular life sciences : CMLS · 2014
    Review
  17. Lipid antigens in immunity.Biological chemistry · 2014
    Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

  • Erratum issued
5 · Who and what money

Authors and funding

10 authors at 3 institutions in 2 countries.

Karen MuindiDivision of Rheumatology, Immunology and Allergy, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA.
Manuela Cernadas
Gerald F M Watts
Louise Royle
David C A Neville
Raymond A Dwek
Gurdyal S Besra
Pauline M Rudd
Terry D Butters
Michael B Brenner
University of Oxford · GBBrigham and Women's Hospital · USUniversity of Birmingham · GB

Funding

T LYMPOHOCYTE RECOGNITIONR01AI028973 · NIAID · DANA-FARBER CANCER INSTITUTE · PI BRENNER, MICHAEL B. · 1990 to 2014
$4.5M
CD1d-restricted T Cell Self-antigens and InfectionR01AI063428 · NIAID · BRIGHAM AND WOMEN'S HOSPITAL · PI BRENNER, MICHAEL B. · 2005 to 2015
$3.9M
T LYMPHOCYTE RECOGNITIONR37AI028973 · NIAID · BRIGHAM AND WOMEN'S HOSPITAL · PI BRENNER, MICHAEL B · 1995 to 2004
$1.7M
CD1d and NKT Cell Activation and Function in InfectionR56AI063428 · NIAID · BRIGHAM AND WOMEN'S HOSPITAL · PI BRENNER, MICHAEL B. · 2010 to 2010
$433k
Medical Research Council G0400421NIAID NIH HHS AI028973NIAID NIH HHS AI063428NIAID NIH HHS R01 AI028973NIAID NIH HHS R01 AI063428NIAID NIH HHS R37 AI028973NIAID NIH HHS R56 AI063428Wellcome Trust 084923/B/08/7
6 · The paper itself

Abstract

Myeloid antigen-presenting cells (APC) express CD1d molecules that present exogenous and endogenous lipid antigens that activate CD1d-restricted T cells, natural killer T (NKT) cells. NKT cell activation has been shown to mediate the potent downstream activation of other immune cells through cell-cell interactions and rapid, prolific cytokine production. Foreign antigens are not required for NKT cell activation. The endogenous lipids bound to CD1d are sufficient for activation of NKT cells in the setting of Toll-like receptor-induced cytokines. The most potent NKT cell antigens identified are glycosphingolipids (GSL). The GSL repertoire of endogenous ligands bound to CD1d molecules that are expressed in myeloid APC at steady state and in the setting of activation has not been delineated. This report identifies the range of GSL bound to soluble murine CD1d (mCD1d) molecules that sample the endoplasmic reticulum/secretory routes and cell surface-cleaved mCD1d that also samples the endocytic system. Specific GSL species are preferentially bound by mCD1d and do not solely reflect cellular GSL. GM1a and GD1a are prominent CD1d ligands for molecules following both the ER/secretory and lysosomal trafficking routes, whereas GM2 was eluted from soluble CD1d but not lysosomal trafficking CD1d. Further, after LPS activation, the quantities of soluble CD1d-bound GM3 and GM1a markedly increased. A unique alpha-galactose-terminating GSL was also found to be preferentially bound to mCD1d at steady state, and it increased with APC activation. Together, these studies identify the range of GSL presented by CD1d and how presentation varies based on CD1d intracellular trafficking and microbial activation.

Indexed as

AnimalsAntigen PresentationAntigen-Presenting CellsAntigens, CD1dBiological TransportCell LineChromatography, High Pressure LiquidEnzyme-Linked Immunosorbent AssayFluorescenceGlycosphingolipidsHumansLymphocyte ActivationMiceMicroscopy, ConfocalNatural Killer T-CellsAntigens, CD1dCd1d1 protein, mouseGlycosphingolipids

Identifiers

PMID20133624
PMCPMC2840327
OpenAlexW2069903274

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.